Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PCPG | rs12919938 | chr16:1699265 | T/A | 5.1E-5 | 177 | 25.28 | 19.3 | 19.83 | KM Plot |
| PCPG | rs12922047 | chr16:90155441 | T/G | 8.74E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |
| PCPG | rs12922553 | chr16:1760091 | A/G | 5.3E-5 | 176 | 25.47 | 18.75 | 17.77 | KM Plot |
| PCPG | rs12922644 | chr16:1776190 | C/T | 0 | 170 | 25.6 | 24.1 | 2.93 | KM Plot |
| PCPG | rs12925525 | chr16:1773914 | G/T | 0 | 171 | 25.6 | 21.7 | 2.93 | KM Plot |
| PCPG | rs12926146 | chr16:1694225 | G/T | 4.72E-5 | 178 | 25.28 | 22.73 | 19.83 | KM Plot |
| PCPG | rs12927006 | chr16:71549911 | A/G | 0 | 177 | 24.53 | 28.47 | 3.17 | KM Plot |
| PCPG | rs12927456 | chr16:71505706 | A/G | 0 | 177 | 24.5 | 28.47 | 3.17 | KM Plot |
| PCPG | rs12930056 | chr16:89946649 | C/A | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
| PCPG | rs12930313 | chr16:1765232 | A/G | 6.54E-5 | 174 | 25.6 | 15.85 | 17.77 | KM Plot |
| PCPG | rs12930606 | chr16:89946682 | A/G | 0.000157 | 176 | 25.77 | 21.5 | 36.37 | KM Plot |
| PCPG | rs12930612 | chr16:12072203 | G/A | 0.000292 | 175 | 25.6 | 24.53 | 25.57 | KM Plot |
| PCPG | rs12930631 | chr16:90084157 | G/A | 0.000473 | 171 | 24.77 | 27.6 | 21 | KM Plot |
| PCPG | rs12933317 | chr16:89828220 | A/G | 0.000179 | 176 | 25.87 | 20.17 | 36.37 | KM Plot |
| PCPG | rs12934529 | chr16:1765483 | T/C | 6.54E-5 | 174 | 25.6 | 15.85 | 17.77 | KM Plot |